242 related articles for article (PubMed ID: 33832440)
1. Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development.
Gruca A; Ziemska-Legiecka J; Jarnot P; Sarnowska E; Sarnowski TJ; Grynberg M
BMC Bioinformatics; 2021 Apr; 22(1):182. PubMed ID: 33832440
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
3. Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.
Ahmed SF; Quadeer AA; McKay MR
Viruses; 2020 Feb; 12(3):. PubMed ID: 32106567
[TBL] [Abstract][Full Text] [Related]
4. In silico discovery of antigenic proteins and epitopes of SARS-CoV-2 for the development of a vaccine or a diagnostic approach for COVID-19.
Can H; Köseoğlu AE; Erkunt Alak S; Güvendi M; Döşkaya M; Karakavuk M; Gürüz AY; Ün C
Sci Rep; 2020 Dec; 10(1):22387. PubMed ID: 33372181
[TBL] [Abstract][Full Text] [Related]
5. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2.
Dawood RM; El-Meguid MA; Salum GM; El-Wakeel K; Shemis M; El Awady MK
J Infect Public Health; 2021 Feb; 14(2):169-178. PubMed ID: 33486372
[TBL] [Abstract][Full Text] [Related]
7. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
8. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
Front Immunol; 2021; 12():692937. PubMed ID: 34497604
[TBL] [Abstract][Full Text] [Related]
9. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
Oliveira SC; de Magalhães MTQ; Homan EJ
Front Immunol; 2020; 11():587615. PubMed ID: 33193414
[TBL] [Abstract][Full Text] [Related]
10. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F
Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015
[TBL] [Abstract][Full Text] [Related]
11. Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins.
Tajuelo A; López-Siles M; Más V; Pérez-Romero P; Aguado JM; Briz V; McConnell MJ; Martín-Galiano AJ; López D
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328398
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
13. Landscape and selection of vaccine epitopes in SARS-CoV-2.
Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
[TBL] [Abstract][Full Text] [Related]
14. Human CD4
Verhagen J; van der Meijden ED; Lang V; Kremer AE; Völkl S; Mackensen A; Aigner M; Kremer AN
Clin Exp Immunol; 2021 Sep; 205(3):363-378. PubMed ID: 34061349
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
[TBL] [Abstract][Full Text] [Related]
16. Immunoinformatics prediction of overlapping CD8
Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
[TBL] [Abstract][Full Text] [Related]
17. The immunodominant and neutralization linear epitopes for SARS-CoV-2.
Lu S; Xie XX; Zhao L; Wang B; Zhu J; Yang TR; Yang GW; Ji M; Lv CP; Xue J; Dai EH; Fu XM; Liu DQ; Zhang L; Hou SJ; Yu XL; Wang YL; Gao HX; Shi XH; Ke CW; Ke BX; Jiang CG; Liu RT
Cell Rep; 2021 Jan; 34(4):108666. PubMed ID: 33503420
[TBL] [Abstract][Full Text] [Related]
18. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
[TBL] [Abstract][Full Text] [Related]
19. An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study.
Yang Z; Bogdan P; Nazarian S
Sci Rep; 2021 Feb; 11(1):3238. PubMed ID: 33547334
[TBL] [Abstract][Full Text] [Related]
20. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]